{"nct_id":"NCT01261767","title":"First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerability and Early Signals of Biologic and Clinical Effects","status":"TERMINATED","status_verified_date":"2017-02","start_date":"2008-04","start_date_type":null,"primary_completion_date":"2011-01","primary_completion_date_type":"ACTUAL","completion_date":"2011-01","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVO"]}